Implications of complement activation in the efficacy of the monoclonal antibody cetuximab against lung cancer cells

Tesis doctoral de Yi-fan Hsu

Background: cetuximab, an antibody targeting the epidermal growth factor receptor (egfr), increases survival in patients with advanced egfr-positive non-small cell lung cancer when administrated in combination with chemotherapy. In this study, we investigated the role of complement activation in the antitumor mechanism of this therapeutic drug. results: egfr-expressing lung cancer cell lines were able to bind cetuximab and initiate complement activation by the classical pathway, irrespective of the mutational status of egfr. This activation led to deposition of complement components and increase in complement-mediated cell death. The influence of complement activation on the activity of cetuximab in vivo was evaluated in xenografts of a549 lung cancer cells on nude mice. A549 cells express wild-type egfr and have a kras mutation. Cetuximab activity against a549 xenografts was highly dependent on complement activation, since complement depletion completely abrogated the antitumor efficacy of cetuximab. Moreover, cetuximab activity was significantly higher on a549 cells in which a complement inhibitor, factor h, was genetically downregulated. conclusions: we demonstrate for the first time that the in vivo antitumor activity of cetuximab can be associated with a complement-mediated immune response. These results may have important implications for the development of new cetuximab-based therapeutic strategies and for the identification of markers that predict clinical response.

 

Datos académicos de la tesis doctoral «Implications of complement activation in the efficacy of the monoclonal antibody cetuximab against lung cancer cells«

  • Título de la tesis:  Implications of complement activation in the efficacy of the monoclonal antibody cetuximab against lung cancer cells
  • Autor:  Yi-fan Hsu
  • Universidad:  Navarra
  • Fecha de lectura de la tesis:  04/10/2010

 

Dirección y tribunal

  • Director de la tesis
    • Rubén Pio Osés
  • Tribunal
    • Presidente del tribunal: José Luis González larriba
    • María mercedes Garayoa berrueta (vocal)
    • sergio Portal núñez (vocal)
    • alfonso Calvo gonzalez (vocal)

 

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Scroll al inicio